Augmedix

Augmedix converts natural clinician-patient conversation into medical documentation and provides live support, including referrals, orders, and reminders, so clinicians can focus on what matters most: patient care.

The Augmedix platform is powered by a combination of proprietary automation modules and human-expert assistants operating in HIPAA-secure locations to generate accurate, comprehensive, and timely-delivered medical documentation.

Augmedix services are compatible with 35+ specialties and are trusted by more than a dozen American health systems supporting telemedicine, medical offices, clinics, and hospitals. Its customers include AdventistHealth, CHI Health, The US Oncology Network, and Dignity Health.

In October 2020, Augmedix began trading publicly on the OTC markets after a reverse merger with Malo Holdings. One year later, in October 2021, the company announced its uplisting to Nasdaq under the ticker symbol #AUGX.